Denver Investment Advisors LLC reduced its stake in LHC Group (NASDAQ:LHCG) by 48.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,624 shares of the health services provider’s stock after selling 7,110 shares during the period. Denver Investment Advisors LLC’s holdings in LHC Group were worth $518,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Invictus RG purchased a new position in shares of LHC Group during the first quarter valued at about $125,000. US Bancorp DE raised its position in shares of LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after buying an additional 539 shares in the last quarter. First Mercantile Trust Co. purchased a new position in shares of LHC Group during the second quarter valued at about $147,000. Mason Street Advisors LLC raised its position in shares of LHC Group by 7.0% in the first quarter. Mason Street Advisors LLC now owns 3,485 shares of the health services provider’s stock valued at $188,000 after buying an additional 228 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its position in shares of LHC Group by 79.1% in the second quarter. State of Alaska Department of Revenue now owns 2,955 shares of the health services provider’s stock valued at $200,000 after buying an additional 1,305 shares in the last quarter. 84.95% of the stock is owned by hedge funds and other institutional investors.
LHC Group (LHCG) opened at 64.31 on Friday. The company’s 50-day moving average price is $63.27 and its 200-day moving average price is $57.46. LHC Group has a 52-week low of $32.04 and a 52-week high of $69.35. The company has a market cap of $1.18 billion, a price-to-earnings ratio of 28.46 and a beta of 0.77.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. The company had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. LHC Group’s revenue was up 15.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.52 earnings per share. Equities research analysts expect that LHC Group will post $2.39 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This piece was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/08/20/denver-investment-advisors-llc-decreases-stake-in-lhc-group-lhcg.html.
LHCG has been the subject of several research reports. Royal Bank Of Canada reissued a “buy” rating on shares of LHC Group in a research report on Tuesday, June 13th. Jefferies Group LLC reissued a “buy” rating and issued a $65.00 target price on shares of LHC Group in a research report on Friday, June 9th. Benchmark Co. increased their target price on LHC Group from $63.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, June 8th. Stephens set a $69.00 target price on LHC Group and gave the stock a “buy” rating in a research report on Saturday, May 6th. Finally, BidaskClub lowered LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. Nine analysts have rated the stock with a buy rating, LHC Group currently has a consensus rating of “Buy” and a consensus target price of $65.75.
In other LHC Group news, Director Coliseum Capital Management, L sold 14,450 shares of the company’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $65.69, for a total transaction of $949,220.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Donald Dwayne Stelly sold 3,181 shares of the company’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the sale, the chief operating officer now owns 114,235 shares of the company’s stock, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 546,207 shares of company stock valued at $33,813,733. 14.80% of the stock is owned by company insiders.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.